Inebilizumab Treatment in a Patient with Co-occurring AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis: A Case Report and Literature Review (P12-8.012) [0.03%]
视神经脊髓炎谱系疾病合并重症肌无力患者接受Inebilizumab治疗：病例报告及文献回顾(P12-8.012)
Xiaoqian Song,Jingjiao Chen,Xueping Zheng
Xiaoqian Song
Objective: This study aims to delineate the clinical features underlying the concurrent of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies. ...
Frequency of Quality Care in Dementia With Lewy Bodies in Cohorts With and Without Specialty Care (P6-3.012) [0.03%]
具有专科护理和无专科护理的路易体痴呆队列中的优质护理频率(P6-3.012)
Rachael Burke,Zhigang Li,Hannah Jury et al.
Rachael Burke et al.
Objective: To investigate the frequency of quality care in moderate-advanced dementia with Lewy bodies (DLB), including in individuals with and without specialty care. ...
When It Fits a Case of SLIPPERS with Imaging, Histopathology, and Treatment Response (P3-8.017) [0.03%]
当影像学、病理和治疗反应符合SLIPPERS情况时(P3-8.017)
Konrad Kubicki,Thomas Shoemaker
Konrad Kubicki
Objective: To contribute to the scarce literature on Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids (SLIPPERS)-thus, supporting this rare constellation of findings...
Neurological Coma Examination Training in Medical Education (P7-5.012) [0.03%]
神经性昏迷检查训练的医学教育(P7-5.012)
Emma Streveler,Francis Lauzier,Maria Muzammil et al.
Emma Streveler et al.
Objective: We hypothesized that developing standardized training for the neurological coma examination will ensure medical trainees are effectively taught the necessary skills to perform and interpret physical examination...
Sonia Chandra,Denise Coley,Bernard Coley et al.
Sonia Chandra et al.
Objective: Measure the impact of an educational resource for Parkinson's Disease (PD) in Members of the Black Diaspora (MBD) created using a Community Based Participatory Research (CPBR) approach. ...
African-American MS Patients with and Without Early B-cell Repletion After Anti-CD20 Monoclonal Infusion Therapy Have Similarly Low Levels of Disease Activity (P10-1.009) [0.03%]
抗CD20单克隆抗体治疗后非洲裔美国多发性硬化患者早期B细胞补充情况有和无者两者疾病活性均低(P10-1.009)
Hannah Kopinsky,Angie Kim,Abhimanyu Amarnani et al.
Hannah Kopinsky et al.
Objective: To compare disease activity in MS patients of African descent on anti-CD20 therapy with early B-cell repletion ('early repletion', ER) to patients without early B-cell repletion ('normal repletion', NR). ...
Unveiling the Diagnostic and Therapeutic Challenges: A Singular Case of Syphilitic Myelitis in an HIV-Positive Patient (P5-10.007) [0.03%]
揭开诊断和治疗的挑战：一名HIV阳性患者的梅毒性脊髓炎病例(P5-10.007)
Unzela Rahmatullah,Zaka Ahmed,Fathi Massoud Marei Abokalawa et al.
Unzela Rahmatullah et al.
Objective: To present a rare case of syphilitic myelitis in an HIV-positive patient, emphasizing diagnostic challenges, MRI findings, and treatment outcomes. This case underscores the importance of considering syphilitic ...
A Preliminary Analysis of the Acceptability and Feasibility of Biofeedback-Assisted Relaxation Delivered by Physical Therapists for Patients with Migraine (P7-12.002) [0.03%]
物理治疗师提供生物反馈辅助放松的可行性和接受度的初步分析（P7-12.002）
Mia Minen,Julia Dorf,Alexis George et al.
Mia Minen et al.
Objective: To conduct interim analyses to assess the feasibility, acceptability, and preliminary impact of a 6-session, in-person, PT-delivered BAR program for patients with migraine. ...
Randomized Controlled Trial
Neurology. 2025 Apr 8;104(7_Supplement_1):4224. DOI:10.1212/WNL.0000000000211532 2025
Rates of Discontinuation and Nonpublication in Glioma Clinical Trials (P3-6.002) [0.03%]
胶质瘤临床试验的中止率及未发表率(P3-6.002)
Yusra Arafeh,Asmaa Zakria,Nada G Hamam et al.
Yusra Arafeh et al.
Objective: This study aims to analyze the rates of discontinuation and nonpublication in clinical trials related to gliomas, highlighting factors that contribute to these issues. ...
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies: Tri-Site Mayo Clinic Experience (S20.003) [0.03%]
CAR-T细胞治疗血液系统恶性肿瘤期间急性症状性癫痫发作：Mayo诊所三家医院的经验（S20.003）
Brin Freund,Andy Shar,Oluwatoni Betiku et al.
Brin Freund et al.
Objective: To evaluate the incidence and risk factors for ASyS during CAR T-cell therapy. Background: Chimeric antigen receptor T-cell ...
Multicenter Study
Neurology. 2025 Apr 8;104(7_Supplement_1):4228. DOI:10.1212/WNL.0000000000211534 2025